Animal study · mice
SLU-PP-332 cut fat mass and improved insulin sensitivity in obese mice
Checked against the paper Animal studyPublished by PepVault
The takeaway
This mouse study links SLU-PP-332 to less fat mass and better insulin sensitivity in obese mice, but there are no human results here.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2024
- Journal
- J Pharmacol Exp Ther
What they tested
The team wanted to know whether SLU-PP-332, a compound they had built to act on estrogen-related receptors (ERR), would improve metabolism in mouse models of obesity and metabolic syndrome.
How the study was done
A preclinical study in two kinds of obese mice: mice made obese by diet and ob/ob mice. The mice were given SLU-PP-332, and the researchers measured a range of metabolic markers.

What they found
In mice, SLU-PP-332 raised energy expenditure, meaning the calories the body burns, and increased fatty acid oxidation, the breakdown of fat for fuel. The treated mice built up less fat mass. In the metabolic syndrome models, the mice became less obese and their insulin sensitivity improved, meaning their bodies responded better to insulin. The authors describe these changes as resembling the effects of exercise on whole-body metabolism.
What it doesn’t show
This was done only in mice, so it does not show the same effects in people. It tested obese mouse models and did not compare the compound with actual exercise in a human trial.
The paper
Billon et al. A Synthetic ERR Agonist Alleviates Metabolic Syndrome. J Pharmacol Exp Ther. 2024.
The compound
More studies on SLU-PP-332
- SLU-PP-332 improved ejection fraction and survival in miceAnimal study · mice · 2024
- SLU-PP-332 increased exercise endurance in miceAnimal study · mice · 2023
- SLU-PP-332 reversed age-related kidney changes in old miceAnimal study · mice · 2023
- Every study on SLU-PP-332
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.